(Q40483903)

20 September 2017

Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma (English)

1 reference

20 September 2017

Mayumi Suzuki

1

1 reference

20 September 2017

Hidenori Shiraha

2

1 reference

20 September 2017

Tatsuya Fujikawa

3

1 reference

20 September 2017

Nobuyuki Takaoka

4

1 reference

20 September 2017

Naoki Ueda

5

1 reference

20 September 2017

Yutaka Nakanishi

6

1 reference

20 September 2017

Kazuko Koike

7

1 reference

20 September 2017

Akinobu Takaki

8

1 reference

20 September 2017

Yasushi Shiratori

9

1 reference

20 September 2017

language of work or name

English

0 references

publication date

6 December 2004

1 reference

Journal of Biological Chemistry

20 September 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

20 September 2017

280

1 reference

20 September 2017

8

1 reference

20 September 2017

6409-6415

1 reference

Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review

20 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Changes of plasma des-γ-carboxy prothrombin levels in patients with hepatocellular carcinoma in response to vitamin K

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Molecular cloning and expression of human hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

A Peptide Representing the Carboxyl-terminal Tail of the Met Receptor Inhibits Kinase Activity and Invasive Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Transcriptional responses to polypeptide ligands: the JAK-STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

STATs: signal transducers and activators of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

STATs and gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Hepatocyte growth factor stimulates motility, chemotaxis and mitogenesis in ovarian carcinoma cells expressing high levels of c-met

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Human lung cancer cell line producing hepatocyte growth factor/scatter factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

HGF/SF induces mesothelial cell migration and proliferation by autocrine and paracrine pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Growth factor-dependent activation of the MAPK pathway in human pancreatic cancer: MEK/ERK and p38 MAP kinase interaction in uPA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Hepatocyte growth factor has potent anti-proliferative activity in various tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Ligand discrimination in signaling through an ErbB4 receptor homodimer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

STAT-3 activity in chemically-induced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

STAT signaling in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

HBx protein of hepatitis B virus activates Jak1-STAT signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Cytokine receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Serine phosphorylation and negative regulation of Stat3 by JNK

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Cyclin-dependent kinase 5 phosphorylates signal transducer and activator of transcription 3 and regulates its transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

PI3K: downstream AKTion blocks apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

Pathway specificity for Met signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M406714200

21 January 2018

Identifiers

DOI

10.1074/JBC.M406714200

1 reference

20 September 2017

1 reference